Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CANDEX | Bayer | N-050233 DISCN | 1982-01-01 | 1 products |
NILSTAT | Chartwell Pharmaceuticals | N-050299 DISCN | 1982-01-01 | 1 products, RLD |
MYCOSTATIN | Delcor Asset | N-050619 DISCN | 1987-04-09 | 1 products |
NILSTAT | Strides Pharma Global | N-050576 DISCN | 1983-12-22 | 1 products, RLD |
NYSERT | Warner Chilcott | N-050478 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
klayesta | ANDA | 2024-12-19 |
mycostatin | ANDA | 2025-01-22 |
nyamyc | ANDA | 2025-07-09 |
nystatin | ANDA | 2025-07-03 |
nystatin and triamcinolone | ANDA | 2011-05-10 |
nystatin and triamcinolone acetonide | ANDA | 2025-07-07 |
nystatin cream | ANDA | 2023-10-24 |
nystatin topical powder | ANDA | 2023-08-10 |
nystop | ANDA | 2025-04-02 |
triple antibiotic | OTC monograph final | 2017-05-05 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stomatitis | D013280 | EFO_1001904 | K12.1 | 3 | 4 | 2 | 1 | 5 | 14 |
Candidiasis | D002177 | — | B37 | — | 1 | 4 | 1 | 4 | 10 |
Mucositis | D052016 | EFO_1001898 | — | 2 | 2 | 1 | 1 | 4 | 9 |
Infections | D007239 | EFO_0000544 | — | 2 | — | 3 | 1 | 2 | 8 |
Communicable diseases | D003141 | — | — | 1 | — | 2 | 1 | — | 4 |
Sepsis | D018805 | EFO_0001420 | A41.9 | — | — | 1 | 1 | 1 | 3 |
Vaginitis | D014627 | EFO_0005757 | N76 | — | — | 2 | 1 | — | 3 |
Birth weight | D001724 | EFO_0004344 | — | — | — | — | 3 | — | 3 |
Critical illness | D016638 | — | — | — | — | 1 | 1 | — | 2 |
Burns | D002056 | — | T30.0 | — | 1 | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | 2 | — | 1 | — | 4 | 7 |
Oral candidiasis | D002180 | EFO_0007406 | B37.0 | — | 1 | 2 | — | 3 | 6 |
Head and neck neoplasms | D006258 | — | — | 2 | 1 | 1 | — | 1 | 4 |
Oral lichen planus | D017676 | — | — | 1 | 1 | 1 | — | 2 | 4 |
Lichen planus | D008010 | — | L43 | 1 | 1 | 1 | — | 2 | 4 |
Denture stomatitis | D013282 | EFO_1000893 | K12.1 | — | 2 | 1 | — | 1 | 4 |
Bacterial vaginosis | D016585 | EFO_0003932 | — | 1 | — | 2 | — | — | 3 |
Ventilator-associated pneumonia | D053717 | EFO_1001865 | J95.851 | — | 1 | 2 | — | — | 2 |
Bacteremia | D016470 | EFO_0003033 | R78.81 | — | 1 | 2 | — | — | 2 |
Graft vs host disease | D006086 | — | D89.81 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | — | — | — | 1 |
Kidney transplantation | D016030 | — | — | 1 | 1 | — | — | — | 1 |
Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | — | — | 1 |
Cross infection | D003428 | — | — | — | 1 | — | — | — | 1 |
Hematologic neoplasms | D019337 | — | — | — | 1 | — | — | — | 1 |
Anastomotic leak | D057868 | — | — | — | 1 | — | — | — | 1 |
Hiv seropositivity | D006679 | — | — | — | 1 | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | 1 | 1 | — | — | — | 1 |
Non-muscle invasive bladder neoplasms | D000093284 | — | — | 1 | 1 | — | — | — | 1 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 2 | — | — | — | 2 | 4 |
Recurrence | D012008 | — | — | 1 | — | — | — | — | 1 |
Aphthous stomatitis | D013281 | EFO_0003938 | K12.0 | 1 | — | — | — | — | 1 |
Otomycosis | D059249 | — | — | 1 | — | — | — | — | 1 |
Dental caries | D003731 | EFO_0003819 | K02 | 1 | — | — | — | — | 1 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | 1 | — | — | — | — | 1 |
Geographic atrophy | D057092 | — | — | 1 | — | — | — | — | 1 |
Atrophy | D001284 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Immunologic deficiency syndromes | D007153 | — | D84.9 | — | — | — | — | 2 | 2 |
Death | D003643 | PATO_0001422 | — | — | — | — | — | 1 | 1 |
Conization | D019092 | — | — | — | — | — | — | 1 | 1 |
Low-level light therapy | D028022 | — | — | — | — | — | — | 1 | 1 |
Periodontal diseases | D010510 | — | K05.6 | — | — | — | — | 1 | 1 |
Neoplasms | D009369 | — | C80 | — | — | — | — | 1 | 1 |
Drug common name | Nystatin |
INN | nystatin |
Description | Nystatin, sold under the brand name Mycostatin among others, is an antifungal medication. It is used to treat Candida infections of the skin including diaper rash, thrush, esophageal candidiasis, and vaginal yeast infections. It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or applied to the skin.
|
Classification | Small molecule |
Drug class | enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2 |
PDB | — |
CAS-ID | 1400-61-9 |
RxCUI | 7597 |
ChEMBL ID | CHEMBL450895 |
ChEBI ID | — |
PubChem CID | 14960 |
DrugBank | DB00646 |
UNII ID | BDF1O1C72E (ChemIDplus, GSRS) |